Search results
Rock-solid motor: Croatia's Mercedes monument honours emigrants
Homenewshere.com· 2 hours agoLike a mini Mount Rushmore, a vintage Mercedes is emerging from a pile of limestone boulders on the ...
The Kate Middleton-approved brand Me+Em is expanding to the US. I visited its NYC flagship and saw...
Business Insider via Yahoo News· 15 hours agoIt was spacious, with a heavy curtain providing privacy and modern racks floating on the walls. The...
People Are Sharing Their Scariest Travel Stories, And I Think It Cured My Wanderlust
BuzzFeed via Yahoo News· 6 hours agoI walked down the trail, like a switchback, only a little ways. Then I turned to see if I could see...
Recruiting Roundup: The Buzz From LSU Football's Star-Studded Weekend Visitors
Sports Illustrated· 16 hours agoBrian Kelly and the LSU football staff welcomed a myriad of top prospects to Baton Rouge last...
Invent Animate Release New Album ‘Heavener (Definitive)’
Music Feeds via Yahoo News· 11 hours agoAtmospheric metalcore band Invent Animate released their new album “Heavener (Definitive)” on...
Primary primer: What you need to know ahead of Iowa's June 4 primary elections
KCCI 8 Des Moines· 2 days agoWith the drama surrounding the state's presidential caucuses far in the rearview mirror, Iowa voters...
Stream It Or Skip It: ‘Back to Black’ on VOD, a messy Amy Winehouse biopic that makes you wanna say...
Decider· 12 hours agoThis probably goes without saying, but: The memory of Amy deserves better.
7 Full-Length Mirrors That Are Perfect for OOTD Photos & Brightening Rooms
Billboard via Yahoo News· 6 days agoAll products and services featured are independently chosen by editors. However, Billboard may...
Taylor Tomlinson's working day and night with comedy specials and 'After Midnight'
Los Angeles Times· 20 hours agoThe comedian's late-night show is actually more pressure than stand-up, she says, ‘because there’s a...
Precigen shares target lifted on phase 2 data for PRGN-2012 By Investing.com
Investing.com· 2 days agoThe increased target follows the company's presentation of phase 2 data for PRGN-2012, a therapeutic...